AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0

CUSIP: 00163UAD8

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Debt / NOTE 3.250% 6/0
Market price (% of par)
103.06%
Total 13F principal
$291,464,000
Principal change
-$906,000
Total reported market value
$300,997,153
Number of holders
33
Value change
+$8,064,568
Number of buys
16
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 00163UAD8?
CUSIP 00163UAD8 identifies 00163UAD8 - AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0 as of Q1 2018

As of 31 Mar 2018, AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0 was held by 33 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $291,464,000 in principal (par value) of the bond. The largest 10 bondholders included STEELHEAD PARTNERS LLC, CNH PARTNERS LLC, TENOR CAPITAL MANAGEMENT Co., L.P., CAMDEN ASSET MANAGEMENT L P /CA, UBS OCONNOR LLC, City Financial Investment Co Ltd, DEUTSCHE BANK AG\, CITADEL ADVISORS LLC, CALAMOS ADVISORS LLC, and WOLVERINE ASSET MANAGEMENT LLC. This page lists 33 institutional bondholders reporting positions for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.